In neurodegenerative diseases, metformin could make a positive effect by activating AMPK signaling, downregulating mTOR pathway, modulating glucose metabolism, and enhancing mitochondriogenesis and autophagy (64). This evidence concerns the gene MTOR and neurodegenerative disease.